Angus Dalgleish

Angus George Dalgleish was born in May 1950 in Harrow, London.[1][7][8] Initially educated at the Harrow County School for Boys,[7] Dalgleish received a Bachelor of Medicine, Bachelor of Surgery degree from University College London with an intercalated bachelor's degree in Anatomy.[7]

After various positions in the United Kingdom, Dalgleish joined the Royal Flying Doctor Service in Mount Isa, Queensland, then progressed through positions at various hospitals in Brisbane, Australia, before moving to the Ludwig Institute for Cancer Research in Sydney.[7][8]

After completion of his training, Dalgleish returned to work in the UK in 1984 at the Institute of Cancer Research,[7][8] where he helped identify CD4 as the major cellular receptor for HIV.[9] [10][11][12] In 1986, he was appointed to a consulting position at Northwick Park Hospital, in 1991 he was made Foundation Professor of Oncology at St George's, University of London,[7] and in 1994 he was appointed Visiting Professor at the Institute of Cancer Research in London.[13]

In 1997, he founded Onyvax Ltd.,[1] a privately funded biotechnology company developing cancer vaccines, where he held the position as Research Director.[14] The company dissolved in 2013 after filing for insolvency in 2008.[15]

Dalgleish is also a member of the medical board in Bionor Pharma.

Dalgleish is on the scientific advisory board of Immodulon, and has stock options in Immunor AS, a disclosure he made in order to have his research work published.[16]

Dalgleish is a member of the UK Independence Party and stood as a candidate in Sutton & Cheam,[17][18] during the 2015 United Kingdom general election finishing fourth with 10.7% of the vote.[19] Unlike many of his colleagues in the scientific community,[20][21] he campaigned for Leave.EU[22] and appeared on the BBC Radio 4 Today programme presenting the case for Brexit.[23]

Dalgleish is a Eurosceptic and campaigned for Leave.EU and Brexit during the UK withdrawal from the EU as a member of the UKIP.[17][23][24][20] He is an advocate of Leave Means Leave, a Eurosceptic pressure group.[25]

Dalgleish was elected a Fellow of the Academy of Medical Sciences in 2001[2] and is also a Fellow of the Royal College of Physicians the Royal College of Pathologists and a Fellow of the Royal Australasian College of Physicians.[24] His citation on election to FMedSci reads:

Professor Angus Dalgleish is Professor of Oncology at St Georges Hospital Medical School London. He has made seminal observations relating to the virology of HIV. In particular he identified CD4 as a major receptive for HIV in humans, produced the first report of a link between Slim Disease in Africa and HIV infection. He also identified the close correlation between the immune response and the presence of tropical spastic paraparesis in patients infected with the HTLV-1 virus.[2]